Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | lactate dehydrogenase a | 0.0141 | 0.4647 | 0.4647 |
Echinococcus granulosus | lactate dehydrogenase protein | 0.0141 | 0.4647 | 0.4647 |
Toxoplasma gondii | malate dehydrogenase MDH | 0.0141 | 0.4647 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 1 | 1 |
Toxoplasma gondii | lactate dehydrogenase LDH2 | 0.0141 | 0.4647 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0141 | 0.4647 | 0.5 |
Plasmodium falciparum | L-lactate dehydrogenase | 0.0141 | 0.4647 | 0.5 |
Entamoeba histolytica | malate dehydrogenase, putative | 0.0141 | 0.4647 | 0.5 |
Plasmodium vivax | malate dehydrogenase, putative | 0.0141 | 0.4647 | 0.5 |
Echinococcus multilocularis | lactate dehydrogenase protein | 0.0141 | 0.4647 | 0.4647 |
Plasmodium vivax | lactate dehydrogenase | 0.0141 | 0.4647 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 1 | 1 |
Echinococcus multilocularis | lactate dehydrogenase a | 0.0141 | 0.4647 | 0.4647 |
Echinococcus granulosus | L lactate dehydrogenase B chain | 0.0141 | 0.4647 | 0.4647 |
Leishmania major | malate dehydrogenase, putative | 0.0141 | 0.4647 | 0.5 |
Echinococcus granulosus | lactate dehydrogenase a | 0.0141 | 0.4647 | 0.4647 |
Plasmodium falciparum | malate dehydrogenase | 0.0141 | 0.4647 | 0.5 |
Echinococcus multilocularis | geminin | 0.0205 | 1 | 1 |
Brugia malayi | lactate dehydrogenase. | 0.0141 | 0.4647 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | malate dehydrogenase | 0.0141 | 0.4647 | 0.5 |
Echinococcus multilocularis | L lactate dehydrogenase B chain | 0.0141 | 0.4647 | 0.4647 |
Echinococcus multilocularis | lactate dehydrogenase a | 0.0141 | 0.4647 | 0.4647 |
Echinococcus multilocularis | lactate dehydrogenase a | 0.0141 | 0.4647 | 0.4647 |
Toxoplasma gondii | lactate dehydrogenase LDH1 | 0.0141 | 0.4647 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 6.5131 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID540273] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.